Panthera Dental has announced partnerships with TVM Life Science Ventures VII and Emerillon Capital. This financial assistance will allow Panthera Dental to continue its international expansion. These two new partners join Capital Croissance PME in supporting Panthera Dental’s commercial development as it works to bring custom products in the fields of dental implantology and sleep-disordered breathing to a larger customer base.
“I am proud to partner with world-class venture capital funds to ensure that Panthera Dental will become a major player in its field. Those investments enable us to consolidate our physical establishment in the United States and in Europe while also allowing us to keep up with the rapid growth of our export, which we have been experiencing now for several years,” says Gabriel Robichaud, CEO.
“Panthera Dental commercializes innovative products targeting wide-ranging international markets. Our investment will position Panthera Dental as a world leader and concurrently keep its corporate roots in the province of Quebec. Panthera Dental will benefit from TVM Life Science Ventures VII’s European and North American network to facilitate its market access abroad,” says Dr. Luc Marengere, Senior Partner, TVM Life Science Ventures VII.
“We are enthusiastically partnering with Gabriel Robichaud and his team at Panthera Dental, a manufacturer recognized for the excellence of its products. Our investment will enable the company to accelerate its growth, mainly abroad, by drawing in part on the network of CIC Capital, Emerillon Capital’s lead sponsor,” says Pierre Cantin, Senior Investment Director, CIC Capital, on behalf of Emerillon Capital.
Panthera Dental has plans to establish subsidiaries in the United States and Europe, and will increase its production capabilities in the months to come in order to better meet demand in those regions.
